The Effect of Food on the Pharmacokinetics of LY2140023 and LY404039 in Healthy Subjects After Administration of the Commercial Tablet Formulation of LY2140023

Trial Profile

The Effect of Food on the Pharmacokinetics of LY2140023 and LY404039 in Healthy Subjects After Administration of the Commercial Tablet Formulation of LY2140023

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 28 Sep 2012

At a glance

  • Drugs Pomaglumetad methionil (Primary)
  • Indications Schizophrenia
  • Focus Pharmacokinetics
  • Sponsors Eli Lilly
  • Most Recent Events

    • 29 Aug 2012 Status changed from not yet recruiting to withdrawn prior to recruitment.
    • 14 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top